Axogen announced making an inducement grant on July 1, 2024, under NASDAQ listing rule 5635(c)(4) in connection with the hire of a new non-executive employee. In connection with the commencement of employment on June 17, 2024, and as a material inducement of employment, an award was made under the Company’s Inducement Equity Incentive plan consisting of restricted stock units representing 10,000 shares of the Company’s common stock. The RSUs are subject to vesting over 4 years, with 50% vesting after the second year and 25% of the total shares granted vesting every year thereafter for the next two years, subject to continuous employment. In accordance with NASDAQ listing rule 5635(c)(4), the equity was granted as a material inducement to employment and was approved by the Compensation Committee of the Axogen’s Board of Directors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXGN:
- Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
- AxoGen announces full launch of Avive+ Soft Tissue Matrix
- Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
- AxoGen’s Annual Meeting Decisions and Director Changes
- Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia